When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale

Authors: Fisher, L., Hessler, DM., Polonsky, WH., Mullan, J.

Abstract

Objective: To identify the pattern of relationships between the 17-item Diabetes Distress Scale (DDS17) and diabetes variables to establish scale cut points for high distress among patients with type 2 diabetes.

Research design and methods: Recruited were 506 study 1 and 392 study 2 adults with type 2 diabetes from community medical groups. Multiple regression equations associated the DDS17, a 17-item scale that yields a mean-item score, with HbA(1c), diabetes self-efficacy, diet, and physical activity. Associations also were undertaken for the two-item DDS (DDS2) screener. Analyses included control variables, linear, and quadratic (curvilinear) DDS terms.

Results: Significant quadratic effects occurred between the DDS17 and each diabetes variable, with increases in distress associated with poorer outcomes: study 1 HbA(1c) (P < 0.02), self-efficacy (P < 0.001), diet (P < 0.001), physical activity (P < 0.04); study 2 HbA(1c) (P < 0.03), self-efficacy (P < 0.004), diet (P < 0.04), physical activity (P = NS). Substantive curvilinear associations with all four variables in both studies began at unexpectedly low levels of DDS17: the slope increased linearly between scores 1 and 2, was more muted between 2 and 3, and reached a maximum between 3 and 4. This suggested three patient subgroups: little or no distress, <2.0; moderate distress, 2.0-2.9; high distress, ≥3.0. Parallel findings occurred for the DDS2.

Conclusions: In two samples of type 2 diabetic patients we found a consistent pattern of curvilinear relationships between the DDS and HbA(1c), diabetes self-efficacy, diet, and physical activity. The shape of these relationships suggests cut points for three patient groups: little or no, moderate, and high distress.

Source: https://pubmed.ncbi.nlm.nih.gov/22228744/

Share the Post:

BDI Monthly Events

January 26
January 26Virtual Presentation
January 26: Dr. Guzman (BDI Director of Clinical Education) will virtually present “The Emotional Side of Diabetes” to the CDCES team at Weill Cornell Medicine in NYC.
January 6
January 6Panel Presentation
January 6: Dr. Polonsky (BDI President) will be joining the panel presentation, “The Rise of Liveable Tech: Calm, Intelligent and Human-First”, at CES 2026, in Las Vegas (NV). https://www.ces.tech/schedule/the-rise-of-liveable-tech-calm-intelligent-and-human-first-presented-by-insulet/
January 14
January 14Case Consultation
January 14: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at [email protected] if you are in the greater San Diego area and would like further information about this program.